Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
about
Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Risk of Tuberculosis Reactivat ...... on-Anti-TNF-Targeted Biologics
@ast
Risk of Tuberculosis Reactivat ...... on-Anti-TNF-Targeted Biologics
@en
type
label
Risk of Tuberculosis Reactivat ...... on-Anti-TNF-Targeted Biologics
@ast
Risk of Tuberculosis Reactivat ...... on-Anti-TNF-Targeted Biologics
@en
prefLabel
Risk of Tuberculosis Reactivat ...... on-Anti-TNF-Targeted Biologics
@ast
Risk of Tuberculosis Reactivat ...... on-Anti-TNF-Targeted Biologics
@en
P2860
P50
P921
P356
P1476
Risk of Tuberculosis Reactivat ...... on-Anti-TNF-Targeted Biologics
@en
P2093
Carlotta Nannini
Laura Niccoli
P2860
P304
P356
10.1155/2017/8909834
P5008
P577
2017-06-01T00:00:00Z